|
|
Volumn 5, Issue 2, 1999, Pages 56-58
|
|
Sepsis and mediator-directed therapy: Rethinking the target populations
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
BIOCHEMICAL MARKER;
INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
PROSTAGLANDIN RECEPTOR BLOCKING AGENT;
THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;
CLINICAL FEATURE;
CLINICAL RESEARCH;
CONFERENCE PAPER;
HUMAN;
INFECTION;
INFLAMMATION;
MEDIATOR RELEASE;
PATIENT CODING;
POPULATION STRUCTURE;
SEPSIS;
ANTI-INFLAMMATORY AGENTS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CLINICAL TRIALS;
HUMANS;
SEPSIS;
STEROIDS;
|
|
EID: 0033051577
PISSN: 13574310
EISSN: None
Source Type: Journal
DOI: 10.1016/S1357-4310(98)01413-0 Document Type: Conference Paper |
|
Times cited : (14)
|
|
References (0)
|
